Instructions for Revalgin (Fenpiverinium bromide, Pitofenone, Metamizole)
English product name
Revalgin
Release form
tab 500 mg+5 mg+100 mcg: 10, 20, 30, 40, 50, 60, 80, 100 or 200 pcs
Description:
The tablets are white to almost white in color, flat, round, smooth, with chamfer on both sides and risk on one side.
1 tab.
methamizol 500 mg
pitofenone hydrochloride 5 mg
phenpiverine bromide 100 ug
Auxiliary substances:
starch,
lactose,
cellulose microcrystalline,
silicon dioxide colloid,
magnesium stearate,
talc.
ATC codes
N02BB52 Sodium methamisole in combination with other drugs Revalgin (excluding psycholeptics)
Clinical-pharmacological groups / Group affiliation
Spasmoanalgetic
Active substance
- pitofenone hydrochloride
- phenpiverine bromide
- methamizol
Pharmacotherapy group Revalgin:
Analgesic nonarcotic agent (analgesic nonarcotic+spasmolytic)
Storage Conditions
Store in a dry place at a temperature not higher than 25°C. Store in places inaccessible to children.
Best before date
Shelf life is 3 years.
Testimony Revalgin:
- mild to moderate pain syndrome in spasms of smooth muscles of internal organs - renal and jaundiced colic, intestinal
- spasms,
- dysmenorrhea and other spastic states of internal organs;
- for short-term symptomatic treatment for headaches,
- migraine pain,
- joint pain,
- neuralgia,
- scialgia,
- myalgia;
- As an aid, it can be used to reduce pain after surgical and diagnostic interventions;
To reduce the high body temperature for colds and infectious inflammatory diseases.
How to take the drug:
Adults and adolescents over 15 years of age are prescribed one - two tablets two - three times/day. The daily dose should not exceed 6 tabi. The duration of the intake is not more than five days.
An increase in the daily dose or duration of treatment is possible only under the supervision of a doctor.
In children, the drug Revalgin is used only by a doctor. Dosage for children six -eight years -1/2 tablet; For children aged 9-12 - 3/4 tablets; For children aged 13-15, one tablet each; assignment multiplicity - 2-3 times/day.
Pharmacological effect:
Spasmoanalgesic. The preparation includes a non-narcotic analgesic of sodium metamisole (analgin), a myotropic spasmolytic agent of pitophenone hydrochloride and a choline-inhibiting agent of fenpiverine bromide.
Methamisol is a pyrazolone derivative. It has analgesic, antipyretic and anti-inflammatory effects.
Pitophenone, like papaverine, has a direct myotropic effect on the smooth musculature of the internal organs and causes its relaxation.
Fenpiverinium, due to its cholin-blocking action, has an additional relaxing effect on smooth muscles.
The combination of the three components of the preparation leads to mutual reinforcement of the pharmacological action thereof, which results in pain relief, relaxation of smooth muscles and a reduction in the increased body temperature.
Application for kidney disorders
Contraindication: Pronounced kidney dysfunction.
Use in liver disorders
Contraindication: marked liver dysfunction.
Terms of Sale
No doctor's prescription.
Use in children
In children, the drug Revalgin is used only by a doctor. The pill is not used for children under 5 years of age.
Nosology (ICD codes)
G43
Migraine
J06.9
Acute upper respiratory tract infection unspecified
J10
Influenza caused by an identified seasonal influenza virus
K80
Gallstone disease [cholelitiasis] (incl. hepatic colic)
K82.8
Other refined diseases of the gallbladder and bubble duct (including dyskinesia)
M25.5
Joint pain
M54.1
Radikulopathy
M54.3
Ishias
M54.4
Lumbago with Sciatica
M79.1
Mialgia
M79.2
Neuralgia and Neuritis Unspecified
N23
Renal colic unspecified
N94.4
Primary dysmenorrhea
N94.5
Secondary dysmenorrhea
R10.4
Other and unspecified abdominal pain (colic)
R50
Fever of uncertain origin
R51
Headache
R52.0
Acute pain
R52.2
Other persistent pain (chronic)
